TABLE OF CONTENTS
Volume 8, Issue 3 (September 2005)
Editorial
Report from Durham
J W Moul Most respectfully,
Prostate Cancer Prostatic Dis 8: 201; doi:10.1038/sj.pcan.4500829
Research Highlights
Prostate News
Prostate Cancer Prostatic Dis 8: 202-205; doi:10.1038/sj.pcan.4500830
Papers
Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): a systematic analysis of expert opinion
F C Lowe, J Batista, R Berges, E Chartier-Kastler, G Conti, F Desgrandchamps, K Dreikorn, M O'Leary, M Perez, M Speakman, J Trachtenberg, A Tubaro, B Meesen, L Smets and H Stoevelaar
Prostate Cancer Prostatic Dis 8: 206-209; advance online publication, June 14, 2005; doi:10.1038/sj.pcan.4500806
Switch from phytotherapy to tamsulosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
A J Gross, M Busse, J Leonard and H Schumacher
Prostate Cancer Prostatic Dis 8: 210-214; advance online publication, May 10, 2005; doi:10.1038/sj.pcan.4500803
Effect of short-term finasteride therapy on peroperative bleeding in patients who were candidates for transurethral resection of the prostate (TUR-P): a randomized controlled study
Ö L Özdal, C Özden, K Benli, S Gökkaya, S Bulut and A Memi
Prostate Cancer Prostatic Dis 8: 215-218; advance online publication, July 5, 2005; doi:10.1038/sj.pcan.4500818
Evaluation of a new, rapid, qualitative, one-step PSA Test for prostate cancer screening: the PSA RapidScreen test
R Miano, G O Mele, S Germani, P Bove, S Sansalone, P F Pugliese and F Micali
Prostate Cancer Prostatic Dis 8: 219-223; advance online publication, May 17, 2005; doi:10.1038/sj.pcan.4500802
Impact of hormone therapy on acute radiotherapy toxicity in the treatment of prostate cancer
A B Jani, J Gratzle and M Myers
Prostate Cancer Prostatic Dis 8: 224-228; advance online publication, June 28, 2005; doi:10.1038/sj.pcan.4500812
Adjuvant and salvage treatment after radical prostatectomy: current practice in the UK
L W Lee, N W Clarke, V A C Ramani, R A Cowan, J P Wylie and J P Logue
Prostate Cancer Prostatic Dis 8: 229-234; advance online publication, July 5, 2005; doi:10.1038/sj.pcan.4500816
Role of transrectal ultrasound guided salvage cryosurgery for recurrent prostate carcinoma after radiotherapy
B J Donnelly, J C Saliken, D S Ernst, B Weber, J W Robinson, P M A Brasher, M Rose and J Rewcastle
Prostate Cancer Prostatic Dis 8: 235-242; advance online publication, June 28, 2005; doi:10.1038/sj.pcan.4500811
Prostate cancer and consistency of reporting sexual histories in men over age 50
L K Dennis, J M Ritchie and M I Resnick
Prostate Cancer Prostatic Dis 8: 243-247; advance online publication, June 28, 2005; doi:10.1038/sj.pcan.4500810
Quantitative real-time reverse transcription: polymerase chain reaction of prostate-specific antigen (PSA) for detection of circulating prostatic cells in patients with clinically localized prostate cancer
L Llanes, A Ferruelo, M Luján, C Pascual, J M García-Mediero and A Berenguer
Prostate Cancer Prostatic Dis 8: 248-252; advance online publication, May 17, 2005; doi:10.1038/sj.pcan.4500801
Comparison of Fc-osteoprotegerin and zoledronic acid activities suggests that zoledronic acid inhibits prostate cancer in bone by indirect mechanisms
J E Quinn, L G Brown, J Zhang, E T Keller, R L Vessella and E Corey
Prostate Cancer Prostatic Dis 8: 253-259; advance online publication, July 5, 2005; doi:10.1038/sj.pcan.4500815
Expression of thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, and orotate phosphoribosyl transferase in prostate cancer
Y Miyoshi, H Uemura, H Ishiguro, H Kitamura, N Nomura, P V Danenberg and Y Kubota
Prostate Cancer Prostatic Dis 8: 260-265; advance online publication, July 5, 2005; doi:10.1038/sj.pcan.4500817
A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo
J K J Diss, D Stewart, F Pani, C S Foster, M M Walker, A Patel and M B A Djamgoz
Prostate Cancer Prostatic Dis 8: 266-273; advance online publication, August 9, 2005; doi:10.1038/sj.pcan.4500796
Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP
J Kang, J Bu, Y Hao and F Chen
Prostate Cancer Prostatic Dis 8: 274-279; advance online publication, May 17, 2005; doi:10.1038/sj.pcan.4500798
Antitumor effect of antisense ODC adenovirus on human prostate cancer cells
Y Zhang, X X Liu, B Zhang, H Y Hu and L Gong
Prostate Cancer Prostatic Dis 8: 280-286; advance online publication, August 16, 2005; doi:10.1038/sj.pcan.4500808
Case Reports
Case study: management of lymph node-positive disease detected at radical prostatectomy
Roger Kirby
Prostate Cancer Prostatic Dis 8: 287-289; advance online publication, June 7, 2005; doi:10.1038/sj.pcan.4500813
Case study: management of advanced prostate cancer with soft tissue metastases
Roger Kirby
Prostate Cancer Prostatic Dis 8: 290-292; advance online publication, June 7, 2005; doi:10.1038/sj.pcan.4500814
Metastatic prostate cancer presenting as an asymptomatic neck mass
J Carleton, P van der Riet and P Dahm
Prostate Cancer Prostatic Dis 8: 293-295; advance online publication, May 17, 2005; doi:10.1038/sj.pcan.4500805
